Vernon C. Langston

626 total citations
33 papers, 456 citations indexed

About

Vernon C. Langston is a scholar working on Pharmacology, Small Animals and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Vernon C. Langston has authored 33 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Small Animals and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Vernon C. Langston's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Vernon C. Langston is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Vernon C. Langston collaborates with scholars based in United States. Vernon C. Langston's co-authors include Andrew J. Mackin, Kari V. Lunsford, Todd Archer, Claire L. Fellman, D.M. Boothe, Lesya M. Pinchuk, R. R. H. Lovell, John V. Stokes, Francis D. Galey and Robert W. Wills and has published in prestigious journals such as Journal of the American Veterinary Medical Association, The AAPS Journal and Journal of Veterinary Internal Medicine.

In The Last Decade

Vernon C. Langston

32 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vernon C. Langston United States 13 132 104 68 67 67 33 456
Patty J. Ewing United States 15 84 0.6× 78 0.8× 156 2.3× 74 1.1× 16 0.2× 32 633
Buket Cicioğlu Arıdoğan Türkiye 16 41 0.3× 48 0.5× 164 2.4× 46 0.7× 70 1.0× 60 773
JJ Egan Ireland 10 55 0.4× 47 0.5× 48 0.7× 265 4.0× 18 0.3× 17 673
R. Lissner Germany 14 16 0.1× 180 1.7× 69 1.0× 39 0.6× 87 1.3× 46 659
C. Gilmore United Kingdom 13 91 0.7× 114 1.1× 138 2.0× 25 0.4× 12 0.2× 15 788
Vijitr Boonpucknavig Thailand 18 48 0.4× 40 0.4× 85 1.3× 34 0.5× 108 1.6× 42 861
Claire L. Fellman United States 11 29 0.2× 26 0.3× 102 1.5× 53 0.8× 107 1.6× 24 376
Alessandra Gavazza Italy 10 25 0.2× 60 0.6× 22 0.3× 119 1.8× 21 0.3× 34 312
Daniel G. Kenney Canada 14 37 0.3× 60 0.6× 26 0.4× 24 0.4× 11 0.2× 28 451
S.N. Sauter Switzerland 13 16 0.1× 281 2.7× 62 0.9× 291 4.3× 104 1.6× 19 729

Countries citing papers authored by Vernon C. Langston

Since Specialization
Citations

This map shows the geographic impact of Vernon C. Langston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vernon C. Langston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vernon C. Langston more than expected).

Fields of papers citing papers by Vernon C. Langston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vernon C. Langston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vernon C. Langston. The network helps show where Vernon C. Langston may publish in the future.

Co-authorship network of co-authors of Vernon C. Langston

This figure shows the co-authorship network connecting the top 25 collaborators of Vernon C. Langston. A scholar is included among the top collaborators of Vernon C. Langston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vernon C. Langston. Vernon C. Langston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ross, Matthew K., et al.. (2025). Plasma Pharmacokinetics of Topical 0.1% Diclofenac Sodium and 0.5% Ketorolac Tromethamine in Dogs. Veterinary Ophthalmology. 29(2). e70105–e70105.
2.
Langston, Vernon C., Robert W. Wills, William S. Denney, et al.. (2021). Pharmacokinetics and pharmacodynamics of intravenous continuous rate infusion and repeated intramuscular administration of dexmedetomidine in standing horses. Journal of Veterinary Pharmacology and Therapeutics. 44(4). 533–543. 2 indexed citations
3.
Cridge, Harry, et al.. (2020). Mefenoxam, Itraconazole, and Terbinafine Combination Therapy for Management of Pythiosis in Dogs (Six Cases). Journal of the American Animal Hospital Association. 56(6). 307–307. 12 indexed citations
4.
Archer, Todd, D.M. Boothe, Vernon C. Langston, et al.. (2013). Oral Cyclosporine Treatment in Dogs: A Review of the Literature. Journal of Veterinary Internal Medicine. 28(1). 1–20. 70 indexed citations
5.
Thomason, John M., John V. Stokes, Lesya M. Pinchuk, et al.. (2012). The Effects of Cyclosporine on Platelet Function and Cyclooxygenase Expression in Normal Dogs. Journal of Veterinary Internal Medicine. 26(6). 1389–1401. 11 indexed citations
6.
Thomason, John M., John V. Stokes, Lesya M. Pinchuk, et al.. (2011). Platelet Cyclooxygenase Expression in Normal Dogs. Journal of Veterinary Internal Medicine. 25(5). 1106–1112. 17 indexed citations
7.
Archer, Todd, Claire L. Fellman, John V. Stokes, et al.. (2011). Pharmacodynamic Monitoring of Canine T-Cell Cytokine Responses to Oral Cyclosporine. Journal of Veterinary Internal Medicine. 25(6). 1391–1397. 36 indexed citations
8.
Langston, Vernon C., et al.. (2010). Evaluation of in vitro serial antibiotic elution from meropenem-impregnated polymethylmethacrylate beads after ethylene oxide gas and autoclave sterilization. Veterinary and Comparative Orthopaedics and Traumatology. 24(1). 39–44. 10 indexed citations
9.
Lunsford, Kari V., Andrew J. Mackin, Vernon C. Langston, & Marjory B. Brooks. (2009). Pharmacokinetics of Subcutaneous Low Molecular Weight Heparin (Enoxaparin) in Dogs. Journal of the American Animal Hospital Association. 45(6). 261–267. 18 indexed citations
10.
Martinez, Marilyn N., Bernadette Dunham, Robert P. Hunter, et al.. (2005). American Academy of Veterinary Pharmacology and Therapeutics 14th Biennial Symposium. Journal of Veterinary Pharmacology and Therapeutics. 28(5). 495–498. 1 indexed citations
11.
12.
Mackin, Andrew J., Carolyn R. Boyle, Weiying Hou, et al.. (2004). Relationship between Red Blood Cell Thiopurine Methyltransferase Activity and Myelotoxicity in Dogs Receiving Azathioprine. Journal of Veterinary Internal Medicine. 18(3). 339–345. 12 indexed citations
13.
Mackin, Andrew J., Carolyn R. Boyle, Weiying Hou, et al.. (2004). Relationship between Red Blood Cell Thiopurine Methyltransferase Activity and Myelotoxicity in Dogs Receiving Azathioprine. Journal of Veterinary Internal Medicine. 18(3). 339–339. 14 indexed citations
14.
Martinez, Marilyn N., Vernon C. Langston, T. Martin, & Dale P. Conner. (2002). Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective. Journal of Veterinary Pharmacology and Therapeutics. 25(3). 201–220. 11 indexed citations
15.
Langston, Vernon C. & Cyril R. Clarke. (2002). The role of the clinical pharmacologist in animal health. PubMed. 4(4). 145–149. 1 indexed citations
16.
Langston, Vernon C., et al.. (1996). Disposition of single‐dose oral enrofloxacin in the horse. Journal of Veterinary Pharmacology and Therapeutics. 19(4). 316–319. 47 indexed citations
17.
18.
KORITZ, G. D., et al.. (1989). Field trial of theophylline in cattle with respiratory tract disease. Journal of the American Veterinary Medical Association. 195(5). 603–605. 3 indexed citations
19.
Langston, Vernon C., et al.. (1988). Uses of vincristine and vinblastine in dogs and cats. Journal of the American Veterinary Medical Association. 193(9). 1114–1117. 37 indexed citations
20.
Langston, Vernon C., Francis D. Galey, R. R. H. Lovell, & William B. Buck. (1985). Toxicity and therapeutics of monensin: a review. Veterinary medicine. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patty J. Ewing Breakdown of academic impact, for papers by Buket Cicioğlu Arıdoğan Breakdown of academic impact, for papers by JJ Egan Breakdown of academic impact, for papers by R. Lissner Breakdown of academic impact, for papers by C. Gilmore Breakdown of academic impact, for papers by Vijitr Boonpucknavig Breakdown of academic impact, for papers by Claire L. Fellman Breakdown of academic impact, for papers by Alessandra Gavazza Breakdown of academic impact, for papers by Daniel G. Kenney Breakdown of academic impact, for papers by S.N. Sauter
Rankless by CCL
2026